Abstract:Cell-intrinsic reporters such as luciferase (LUC) and red fluorescent protein (RFP) have been commonly utilized in preclinical studies to image tumor growth and to monitor therapeutic responses. While extrinsic reporters that emit near infrared I (NIR-I: 650-950 nm) or near-infrared II (NIR-II: 1000 -1700 nm) optical signals have enabled minimization of tissue autofluorescence and light scattering, it has remained unclear as to whether their use has afforded more accurate tumor imaging in small animals. Here, we developed a novel optical imaging construct comprised of rare earth lanthanide nanoparticles coated with biodegradable diblock copolymers and doped with organic fluorophores, generating NIR-I and NIR-II emissive bands upon optical excitation. Simultaneous injection of multiple spectrally-unique nanoparticles into mice bearing tumor implants established via intraperitoneal dissemination of LUC+/ RFP+ OVCAR-8 ovarian cancer cells enabled direct comparisons of imaging with extrinsic vs. intrinsic reporters, NIR-II vs. NIR-I signals, as well as targeted vs. untargeted exogenous contrast agents in the same animal and over time. We discovered that in vivo optical imaging at NIR-II wavelengths facilitates more accurate detection of smaller and earlier tumor deposits, offering enhanced sensitivity, improved spatial contrast, and increased depths of tissue penetration as compared to imaging with visible or NIR-I fluorescent agents. Our work further highlights the hitherto underappreciated enhancements in tumor accumulation that may be achieved with intraperitoneal as opposed to intravenous administration of nanoparticles. Lastly, we found discrepancies in the fidelity of tumor uptake that could be obtained by utilizing small molecules for in vivo as opposed to in vitro targeting of nanoparticles to disseminated tumors. (C) 2017 Elsevier Ltd. All rights reserved.

In Vivo Imaging of Lung Tumor Growth Using In-Line X-Ray Phase Contrast Technique

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Lung Cancer and Angiogenesis Imaging Using Synchrotron Radiation

Detection of Lung Cancer with Phase-Contrast X-ray Imaging Using Synchrotron Radiation

Phase-Contrast Imaging with Synchrotron X-Ray for Mouse Lung

Microbubble-based Synchrotron Radiation Phase Contrast Imaging: Basic Study and Angiography Applications.

Grating-based Phase-Contrast Imaging of Tumor Angiogenesis in Lung Metastases.

In-line phase-contrast and grating-based phase-contrast synchrotron imaging study of brain micrometastasis of breast cancer

Visualizing Treatment Delivery and Deposition in Mouse Lungs Using in Vivo X-Ray Imaging.

Synchrotron-radiation Phase-Contrast Imaging of Human Stomach and Gastric Cancer:In Vitrostudies

Assessment of Fibrotic Tissue and Microvascular Architecture by In-Line Phase-Contrast Imaging in a Mouse Model of Liver Fibrosis

In-line X-ray phase-contrast imaging of murine liver microvasculature ex vivo

A new scheme for real-time high-contrast imaging in lung cancer radiotherapy: a proof-of-concept study

In vivo low-dose phase-contrast CT for quantification of functional and anatomical alterations in lungs of an experimental allergic airway disease mouse model

Comparison of phase contrast CT images for different tumor tissues

Mouse Blood Vessel Imaging by In-Line X-Ray Phase-Contrast Imaging

In Vivo Dynamic Phase-Contrast X-ray Imaging Using a Compact Light Source

SYNCHROTRON RADIATION X-RAY PHASE-CONTRAST IMAGING IN MORPHOLOGY

CO 2 -Based In-Line Phase Contrast Imaging of Small Intestine in Mice

Visualization of angiogenesis by synchrotron radiation in human breast cancer LI Ruimin1, ZHANG Xi1, WANG

Morphological Study of Early-Stage Lung Cancer Using Synchrotron Radiation.